Oct 28, 2024 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q2 FY25 earnings conference call of Sun Pharmaceutical Industries Limited. (Operator Instructions)
I now hand the conference over to Dr. Abhishek Sharma, Vice President, Head, Investor Relations and Strategic Projects. Thank you, and over to you, sir.
Abhishek Sharma - Sun Pharmaceutical Industries Ltd - Investor Relations
Thank you. Good evening, and a warm welcome to our second-quarter FY25 earnings call. I'm Abhishek from the Sun Pharma Investor Relations team. We hope you have received our Q2 financials and the press release that was sent out earlier in the day. These are also available on our website. We have with us Mr. Dilip Shanghvi, Chairman and Managing Director; Mr. C.S. Muralidharan, CFO; Mr. Abhay Gandhi, CEO, North America; and Mr. Kirti Ganorkar, CEO India Business.
Today, the team will provide an update on financial performance and business highlights for the quarter. Pipeline update and respond to any queries -- that any questions that you may have. We will refer to the
Q2 2025 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
Oct 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers